Joined
·
54,587 Posts
http://www.itftennis.com/antidoping/news/pressrelease.asp?articleid=19847
ITF Press Release
Decision in the case of Courtney NagleLondon, England, 02 Apr 2009 - The International Tennis Federation announced that Courtney Nagle has been found to have committed a Doping Offence under Article C.1 of the 2008 Tennis Anti-Doping Programme (presence of a Prohibited Substance in player’s specimen).
Ms Nagle, a 26-year-old tennis player from the United States, provided a sample on 29 July 2008 at the Nordic Light event in Stockholm, Sweden, in which Canrenone was subsequently found to be present. Canrenone is a prohibited substance under WADA’s 2008 List of Prohibited Substances, and is therefore also prohibited under the 2008 Tennis Anti-Doping Programme.
The ITF found that Ms Nagle established how the Canrenone had entered her body and that there had been no intent to enhance her sporting performance. As Canrenone is classified as a “specified substance” under the 2009 Programme, Ms Nagle is entitled to a discretionary reduction from the standard two-year period of Ineligibility that would otherwise have applied under the lex mitior provision of the 2009 WADA Code.
The ITF confirmed the commission of a Doping Offence on 29 March and determined that Ms Nagle should be suspended from participation for a period of sixteen months, the start of which is back-dated to the date of sample collection, and thus ends on 28 November 2009, and that her results from the Nordic Light event should be disqualified, with resulting forfeiture of ranking points and prize money won at those events.
The decision with reasons is available below. Any party wishing to appeal the decision has
three weeks to do so from receipt of the written decision.
ITF Press Release
Decision in the case of Courtney NagleLondon, England, 02 Apr 2009 - The International Tennis Federation announced that Courtney Nagle has been found to have committed a Doping Offence under Article C.1 of the 2008 Tennis Anti-Doping Programme (presence of a Prohibited Substance in player’s specimen).
Ms Nagle, a 26-year-old tennis player from the United States, provided a sample on 29 July 2008 at the Nordic Light event in Stockholm, Sweden, in which Canrenone was subsequently found to be present. Canrenone is a prohibited substance under WADA’s 2008 List of Prohibited Substances, and is therefore also prohibited under the 2008 Tennis Anti-Doping Programme.
The ITF found that Ms Nagle established how the Canrenone had entered her body and that there had been no intent to enhance her sporting performance. As Canrenone is classified as a “specified substance” under the 2009 Programme, Ms Nagle is entitled to a discretionary reduction from the standard two-year period of Ineligibility that would otherwise have applied under the lex mitior provision of the 2009 WADA Code.
The ITF confirmed the commission of a Doping Offence on 29 March and determined that Ms Nagle should be suspended from participation for a period of sixteen months, the start of which is back-dated to the date of sample collection, and thus ends on 28 November 2009, and that her results from the Nordic Light event should be disqualified, with resulting forfeiture of ranking points and prize money won at those events.
The decision with reasons is available below. Any party wishing to appeal the decision has
three weeks to do so from receipt of the written decision.
